Basel Medical (BMGL) Income towards Parent Company (2023 - 2024)

Basel Medical recorded quarterly Income towards Parent Company of -$237753.1 in Q4 2024, down 112.59% quarter-over-quarter from $1.9 million in Q4 2023, and down 112.59% year-over-year from $1.9 million in Q1 2024.

Basel Medical's Income towards Parent Company history runs 2 years deep, the most recent figure standing at -$237753.1 for Q4 2024.

  • In Q4 2024, Income towards Parent Company fell 112.59% year-over-year to -$237753.1; the TTM figure through Jun 2025 stood at $1.7 million (changed N/A YoY), while the FY2025 annual figure was -$8.4 million, down 645.8% from the prior year.
  • Income towards Parent Company came in at -$237753.1 for Q4 2024 at Basel Medical, down from $1.9 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $1.9 million in Q4 2023 to a low of -$237753.1 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn
10 Basel Medical 8.57 Mn 6.23 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 -237,753.06
Dec 31, 2023 1.89 Mn